Fundamentals for Reckitt Benckiser Group
Retrieved 1 December Retrieved 23 September
Muss man sich damit wirklic. Nach so langer Zeit … Anleger sollten dies wissen! Wo soll das nur hinführen? Da bleibt Ihnen die Spucke. Ob das wirklich so spannen. Wer hat das bitte nicht kom. Lohnt sich die Aufruhr? Genau das was haben wir a. Sehr solide Zahlen - Umsatz. Lithium-Lagerstätte mit 1 Mrd. Profil Börsenplätze Historische Kurse. RB's brands include the antiseptic brand Dettol , the sore throat medicine Strepsils , the hair removal brand Veet , the immune support supplement Airborne ,  , the indigestion remedy Gaviscon, the baby food brand Mead Johnson , the air freshener Air Wick , Calgon , Clearasil , Cillit Bang , Durex , Lysol , Mycil and Vanish.
Johann Benckiser founded a business in Pforzheim , Germany in Bart Becht became CEO of the new company and has been credited for its transformation, focusing on core brands and improving efficiency in the supply chain. The new management team's strategy of "innovation marketing". For example, in , the company's "rapid succession of well publicised new product variants" were credited for helping them "to capture shoppers' imagination".
The three main brands acquired were Nurofen 's analgesics , Strepsils sore throat lozenges, and Clearasil anti- acne treatments. On 27 August , RB recalled all remaining stock of its major analgesic product, Nurofen Plus, after packs were found to contain an antipsychotic drug.
In April , Bart Becht announced he was to retire as CEO of Reckitt Benckiser and would be replaced from September by executive vice-president of Category Development, Rakesh Kapoor , who had played a key role in recent acquisitions. In , Reckitt Benckiser announced it was dropping its full name in favour of RB. While some expert analysts viewed this move as a precursor to a possible sale of the home division, Rakesh Kapoor, CEO of Reckitt Benckiser, said that it was only to improve the performance of each of the divisions.
RB is headquartered in Slough , England, and has operations in around 60 countries. Its products are sold in nearly countries. Reckitt Benckiser currently produces the following products: As of , RB's directors were: The Guardian called him "one of the most successful businessmen of his generation". Under him, the company focused on its core brands, and on improving efficiency in the supply chain. It also increased its marketing budget. Reckitt Benckiser shares fell by 6. The company supports Save the Children.
The petition seeks to compel the companies to identify all of the ingredients used in their products. RB and the other defendants ignored or refused the request. In June , RB launched RB Trees then known as Trees for Change , a major forestation project designed to offset the greenhouse gases created as a by-product of its manufacturing processes. The project aims to plant 10,, trees, on land used or previously cleared for cultivation, to turn this back to forest.
According to a BBC report in May , about people, many of them women and children, are reported to have died or been injured after inhaling PHMG. Reckitt Benckiser Korea has been blamed for deaths by a coalition of consumer groups in South Korea;  the April The Korea Herald report said that Reckitt Benckiser Korea had been blamed for deaths. Sometime after the release of the KCDC report, prosecutors in South Korea opened an investigation into the companies selling the disinfectants, which increased its pace in January In May Korean division chief Ataur Safdar apologised to victims and families in a press conference and offered compensation to the families of those who died to those who were injured; it was the first time the company had acknowledged that its products containing PHMG were harmful.
In the BBC's Newsnight accused Reckitt Benckiser of attempting to delay the introduction of a competitive, generic version of one of its most popular products, Gaviscon , a treatment for heartburn and gastroesophageal reflux disease. In his introduction, reporter Martin Shankleman said, "Gaviscon is hailed as a power brand by its owners, Reckitt Benckiser".
He continued, "Reckitt Benckiser likes to claim that the profits flow from their expertise in marketing. But we know that there's another way in which they've been coining it in—-by ripping-off the NHS , as a whistle-blower has told us. The "whistle-blower" was shown in silhouette, and his words were spoken by an actor: It could have saved the NHS millions of pounds. But not just the NHS, patients, doctors—they've cheated health professionals. I felt it had to be exposed". Newsnight claimed that RB had a "secret plan to ensure that it kept its stranglehold" after the Gaviscon patent expired in , and that Newsnight had seen the plan.
The investigation was widely reported in the British press. The Guardian quoted a leaked memo in which the product's manager explained that the company could use "the rationale of health and safety" to design a switched product to "muddy the waters. RB is a responsible company and we have therefore instigated an immediate internal investigation and will take action. However, we do not accept much of what has been alleged.
The Times noted that "Although Gaviscon has been out of patent for almost ten years, no other manufacturer has developed a cheap generic version. It also printed verbatim extracts from several of the leaked memos. In response to the Newsnight report and the reports in the press, RB issued a statement that began:. We are shocked by the allegations made as Reckitt Benckiser is a responsible company in the way it conducts its business. Nevertheless, we are deeply concerned by the inappropriate sentiment expressed in some of the historic internal correspondence reported.
We take this very seriously and have instigated an immediate internal investigation, and will take action. We also refute much of what has been reported which implies a power and influence we simply do not possess.
The company has never objected to a monograph driven generic name being published. The company made appropriate challenges where it felt it was justified in order to ensure patients are prescribed the right treatment. These were within the law and relevant regulations. We stress that the regulators only take a comment into account when it is valid. In , RB created controversy when it emerged that seemingly different versions of their product Nurofen marketed to treat specific pains, such as migraine, were all identical to the standard product despite costing twice as much.
The product was withdrawn from sale in Australia for misleading consumers. In the United States Environmental Protection Agency EPA announced a decision to remove second-generation anticoagulant rodenticides from store shelves, leaving the products available for purchase only by US licensed applicators.
The ruling was slated to go into effect in allowing poison companies time to adjust to the new law. EPA's decision was based on tens of thousands of reports of pet, wildlife and child poisonings that resulted annually from rat poisons in the US alone. Early in , California State Department of Pesticide Regulation ruled that anticoagulant rat poison sales would be restricted beginning on 1 July According to a Amnesty International report, Reckitt Benckiser is one of several consumer companies that buy palm oil from Wilmar International , the world's largest palm oil refiner.
Amnesty found that Wilmer profits from child labour and forced labour and exposes workers to toxic banned chemicals. From Wikipedia, the free encyclopedia. Reckitt Benckiser Group plc Type. Reckitt and Sons and Colman's. Archived from the original on 14 May Retrieved 20 December Retrieved 16 March